IDEAYA Biosciences, Inc. - Common Stock (IDYA)
CUSIP: 45166A102
Q1 2025 13F Holders as of 31 Mar 2025
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 87,533,169
- Total 13F shares
- 93,850,250
- Share change
- +1,657,376
- Total reported value
- $1,541,886,881
- Put/Call ratio
- 38%
- Price per share
- $16.38
- Number of holders
- 204
- Value change
- +$4,216,022
- Number of buys
- 127
- Number of sells
- 74
Quarterly Holders Quick Answers
What is CUSIP 45166A102?
CUSIP 45166A102 identifies IDYA - IDEAYA Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45166A102:
Top shareholders of IDYA - IDEAYA Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
15%
|
12,963,151
|
$333,152,983 | — | 31 Dec 2024 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
8.1%
from 13D/G
|
8,377,056
|
$215,290,340 | — | 31 Dec 2024 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
6.7%
|
5,857,639
|
$150,605,833 | — | 31 Dec 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
5.8%
|
5,078,084
|
$130,506,759 | — | 31 Dec 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
5.8%
|
5,063,526
|
$130,132,618 | — | 31 Dec 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
4.4%
|
3,866,908
|
$99,380,000 | — | 31 Dec 2024 | |
| STATE STREET CORP |
13F
|
Company |
3.8%
|
3,320,898
|
$85,347,079 | — | 31 Dec 2024 | |
| Logos Global Management LP |
13F
|
Company |
3.4%
|
3,000,000
|
$77,100,000 | — | 31 Dec 2024 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
3.1%
|
2,736,000
|
$70,315,200 | — | 31 Dec 2024 | |
| Capital Research Global Investors |
13F
|
Company |
2.9%
|
2,565,897
|
$65,943,553 | — | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.3%
|
1,988,681
|
$51,120,647 | — | 31 Dec 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
2.2%
|
1,941,271
|
$49,890,665 | — | 31 Dec 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.1%
|
1,836,830
|
$47,206,531 | — | 31 Dec 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
2%
|
1,758,133
|
$45,184,018 | — | 31 Dec 2024 | |
| MORGAN STANLEY |
13F
|
Company |
1.8%
|
1,555,080
|
$39,965,557 | — | 31 Dec 2024 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.5%
|
1,347,252
|
$34,624,376 | — | 31 Dec 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.4%
|
1,200,094
|
$30,842,416 | — | 31 Dec 2024 | |
| Fiera Capital Corp |
13F
|
Company |
1.4%
|
1,184,467
|
$30,440,802 | — | 31 Dec 2024 | |
| Avidity Partners Management LP |
13F
|
Company |
1.3%
|
1,126,700
|
$28,956,190 | — | 31 Dec 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
1.2%
|
1,071,825
|
$27,545,903 | — | 31 Dec 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
1.2%
|
1,069,090
|
$27,475,613 | — | 31 Dec 2024 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
1.2%
|
1,062,123
|
$27,296,561 | — | 31 Dec 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
1.1%
|
974,636
|
$25,048,144 | — | 31 Dec 2024 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1%
|
876,599
|
$22,528,593 | — | 31 Dec 2024 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
0.91%
|
792,399
|
$20,364,655 | — | 31 Dec 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.88%
|
771,852
|
$19,836,597 | — | 31 Dec 2024 | |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
|
Company |
0.88%
|
771,844
|
$19,836,391 | — | 31 Dec 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.87%
|
759,883
|
$19,528,993 | — | 31 Dec 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.85%
|
747,934
|
$19,221,907 | — | 31 Dec 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.81%
|
712,811
|
$18,319,243 | — | 31 Dec 2024 | |
| Redmile Group, LLC |
13F
|
Company |
0.71%
|
619,300
|
$15,916,010 | — | 31 Dec 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.67%
|
590,697
|
$15,180,913 | — | 31 Dec 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.64%
|
564,217
|
$14,500,377 | — | 31 Dec 2024 | |
| BOONE CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.6%
|
524,868
|
$13,489,108 | — | 31 Dec 2024 | |
| NORGES BANK |
13F
|
Company |
0.59%
|
520,810
|
$13,384,817 | — | 31 Dec 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.57%
|
498,827
|
$12,819,854 | — | 31 Dec 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.53%
|
460,600
|
$11,837,420 | — | 31 Dec 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.48%
|
423,774
|
$10,890,992 | — | 31 Dec 2024 | |
| UBS Group AG |
13F
|
Company |
0.48%
|
418,485
|
$10,755,065 | — | 31 Dec 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
0.47%
|
414,035
|
$10,640,700 | — | 31 Dec 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.43%
|
372,979
|
$9,585,561 | — | 31 Dec 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.4%
|
346,765
|
$8,910,110 | — | 31 Dec 2024 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.39%
|
341,063
|
$8,765,319 | — | 31 Dec 2024 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.38%
|
331,072
|
$8,508,550 | — | 31 Dec 2024 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.37%
|
323,286
|
$8,308,450 | — | 31 Dec 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.36%
|
312,666
|
$8,035,517 | — | 31 Dec 2024 | |
| Aberdeen Group plc |
13F
|
Company |
0.35%
|
306,723
|
$7,882,781 | — | 31 Dec 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.33%
|
288,002
|
$7,400,518 | — | 31 Dec 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.33%
|
286,759
|
$7,369,706 | — | 31 Dec 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.32%
|
284,267
|
$7,305,662 | — | 31 Dec 2024 |
Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q1 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2025 vs Q4 2024 Across Filers
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 Value $ | Q1 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.